- Home
- ICFI vs DYN Comparison
ICFI vs DYN Comparison
Compare ICFI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICFI
- DYN
- Stock Information
- Founded
- ICFI 1969
- DYN 1984
- Country
- ICFI United States
- DYN United States
- Employees
- ICFI N/A
- DYN N/A
- Industry
- ICFI Professional Services
- DYN Medicinal Chemicals and Botanical Products
- Sector
- ICFI Consumer Discretionary
- DYN Health Care
- Exchange
- ICFI Nasdaq
- DYN Nasdaq
- Market Cap
- ICFI 1.7B
- DYN 1.9B
- IPO Year
- ICFI 2006
- DYN 2020
- Fundamental
- Price
- ICFI $78.14
- DYN $18.84
- Analyst Decision
- ICFI Buy
- DYN Strong Buy
- Analyst Count
- ICFI 4
- DYN 15
- Target Price
- ICFI $116.75
- DYN $36.53
- AVG Volume (30 Days)
- ICFI 209.1K
- DYN 3.1M
- Earning Date
- ICFI 10-30-2025
- DYN 11-05-2025
- Dividend Yield
- ICFI 0.72%
- DYN N/A
- EPS Growth
- ICFI N/A
- DYN N/A
- EPS
- ICFI 5.30
- DYN N/A
- Revenue
- ICFI $1,925,502,000.00
- DYN N/A
- Revenue This Year
- ICFI N/A
- DYN N/A
- Revenue Next Year
- ICFI $2.61
- DYN N/A
- P/E Ratio
- ICFI $14.73
- DYN N/A
- Revenue Growth
- ICFI N/A
- DYN N/A
- 52 Week Low
- ICFI $72.03
- DYN $6.36
- 52 Week High
- ICFI $167.55
- DYN $33.40
- Technical
- Relative Strength Index (RSI)
- ICFI 33.47
- DYN 51.17
- Support Level
- ICFI $78.50
- DYN $18.20
- Resistance Level
- ICFI $84.20
- DYN $20.07
- Average True Range (ATR)
- ICFI 3.33
- DYN 1.58
- MACD
- ICFI -0.27
- DYN -0.55
- Stochastic Oscillator
- ICFI 35.11
- DYN 22.76
About ICFI ICF International Inc.
ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.